Treprostinil Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Treprostinil stocks.

Recent Signals

Date Stock Signal Type
2021-05-14 ASND Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 LQDA 20 DMA Resistance Bearish
2021-05-14 LQDA 50 DMA Support Bullish
2021-05-14 LQDA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
Related Industries: Biotechnology

Treprostinil (marketed under the trade names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation) is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil is a synthetic analog of prostacyclin (PGI2).
The inhaled form of treprostinil was approved by the FDA in July 2009 and is marketed as the trade name Tyvaso.

More about Treprostinil
Browse All Tags